Clinical Trial Update: Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject [Phase 4]

View source ↗

Summary

Phase 4 HIV trial comparing darunavir/ritonavir plus lamivudine to continuing with darunavir/ritonavir plus either tenofovir/emtricitabine or abacavir/lamivudin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (darunavir)
• Emtricitabine (Emtricitabine)
• Lamivudine (lamivudine)
• Ritonavir (Ritonavir)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• abacavir (abacavir)
• abacavir/lamivudine (abacavir/lamivudine)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: HIV Infection | Phase 4 | Status: COMPLETED